Pharma Journalist

Novel Antibody Therapeutics Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Novel Antibody Therapeutics Congress one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Adoptive Cell Transfer Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Adoptive Cell Transfer Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

TMB & Neoantigen Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The TMB & Neoantigen Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Liquid Biopsies Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Liquid Biopsies Congress is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

Flow Cytometry Congress
2019-10-10 - 2019-10-11 | London, United Kingdom – Venue to be confirmed
The Flow Cytometry is one of five co-located conferences exploring key areas in immuno-oncology. The Research & Technology Series will attract over 100 speakers and 350+ attendees. These interactive meetings provide the opportunity to keep up to date with the cutting edge of research and make connections with industry experts, researchers, investors and businesses.

SMi’s 9th Annual Orphan Drugs & Rare Diseases Conference
2019-10-15 - 2019-10-16 | Holiday Inn Kesington Forum, London, UK, London, United Kingdom
SMi Group are proud to announce the 9th Annual Orphan Drugs and Rare Diseases Conference, taking place on the 15th and 16th October 2019 in London, UK.

The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.
This is due to the arising interest for pharmaceutical companies, primarily for the underlying benefits, including the potential discovery of mechanisms for more common diseases, and the involvement of many smaller biotechnology start-up companies who are more focused on rare diseases.
The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerative orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.
BENEFITS OF ATTENDING

HEAR about the success of orphan drug launches following the heavy involvement of patient advocacy programs
DISCUSS the potential changes in assessing the development of medicines across Europe
EXPLORE the future landscape orphan drugs following the market access and reimbursement challenges providers are currently facing.

PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Thursday 17th October 2019
A deep dive into strategies for accelerating patient access of orphan drugs
Workshop Leader: Workshop Leaders: Solange Corriol-Rohou, Senior Director Regulatory Affairs & Policy Europe, AstraZeneca
Cecile Ollivier, Chief Operating Officer, Aparito
WHO SHOULD ATTEND?
CEOs, CSOs, Vice Presidents, Directors, Heads, Principals working in:

Medical Affairs
Medical Advisory
Clinical Operations
Rare Disease Research
Patient Advocacy
Commercial Officer
Orphan Drug Therapeutics
Healthcare
Regulatory Affairs
Rare Disease Charity Officers

For more details and to register or this event, visit the website at http://www.orphandrugs.co.uk/PJWL
EARLY BIRD-RATES

BOOK BY 31ST MAY AND SAVE £400
BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30TH AUGUST AND SAVE £200

Marketing and Customer Innovation Europe
2019-10-15 - 2019-10-16 | Novotel West London One Shortlands, London, W6 8DR, United Kingdom
We’re at a crossroads. On the one hand, pharma marketeers must adopt and master an array of technological innovations to transform customer relationships and better meet rising expectations.
On the other, successful innovation is currently inhibited by our failure to master the basics – with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods, whether it’s digital or education-led initiatives.
Let’s build the capability to create new collaborations and partnerships, both internally and externally, to strengthen what’s possible yet at the same time deliver on the fundamentals of customer-value. It’s no longer a nice-to-have – we must do this or face rapid extinction.
eyeforpharma Marketing and Customer Innovation Europe will bring together 250+ Marketing, Digital, CX, IT/CRM and Business Partnership/Technology pharma executives to bridge internal divides, share the industry pushing case studies and build market-leading customer experiences.
Attend and gain unique insights on:

Collaborate or die.
Break internal silos in commercial and medical affairs, partner with healthcare’s key innovators and decision makers, and bring the brightest FMCG knowledge and leadership inside
You’re brand obsessed!
Create true customer partnerships and influence behaviours with an above-brand, education-led approach
Digital transformation needs a cultural revolution.
Demonstrate the value of digital initiatives to ensure adoption across affiliates and departments
Harness big data.
Personalise customer interactions with an internal infrastructure built to comprehend and connect insights
Achieve customer-centricity.
Ensure new channel innovations and digital investments remain purpose-led to meet customer needs
Real-life technological innovation.
Channel your investments and cut through unnecessary hyperbole with current applications of technology breakthroughs

4 Reasons to Attend:
Case Studies: Practical, tangible advice and actions from your peers which you can put into practise in your own company
Out of Industry Speakers: Hear from some of the biggest leader in marketing out of the pharma industry sharing their top tips
Team Benefits: Group rates are now available for 2+ attendees, to ensure all interested peers can take advantage of this learning opportunity
All Stakeholders in One Room: Working together to ensure we are engaging in solution focused exchanges across all departments
Book before 19th July to save €300

LogiMed 2019
2019-10-16 - 2019-10-17 | ROTTERDAM – NHOW HOTEL
LogiMed is the only European event designed for medical device supply chain directors and their teams. It is where Heads of Supply Chain and Logistics from the top pharma companies in Europe gather to benchmark, interact, network and develop professionally.
Only at LogiMed will you have the chance to learn from and network with all the major medical device companies, key hospitals, and the most innovative industry suppliers. All openly sharing the do’s and don’ts to help you adapt to new regulations, redefine your supply chain strategy-covering planning, logistics and customer service to achieve greater end-to-end supply chain operations.
Download the agenda to find out exactly who is speaking, what the hottest topics are and how LogiMed can benefit you. LogiMed 2019 will bring together 250 Medical Device Supply Chain Professionals and 50 expert speakers over 2 value packed days.
Mixing interactive presentations from Global Heads of Supply Chain with practical, interactive ‘how to’ case studies from proven procurement experts; LogiMed helps Medical Device Manufacturers to transform their supply chain.
As a proud Media partner of the event, we are pleased to offer you an exclusive 15% discount off the full price to attend, using our code: PHARMAJOUR19
Book your place online here: https://bit.ly/2J5viSu

Highly Potent Active Pharmaceutical Ingredients USA (HPAPI) Conference
2019-10-21 - 2019-10-22 | Sheraton Boston Hotel, Boston USA, United States
SMi is delighted to announce its USA Highly Potent Active Pharmaceutical Ingredients conference coming to Boston on the 21th – 22th October 2019.
The inaugural HPAPI USA conference will explore how current technologies are streamlining the HPAPI industry with artificial intelligence and machine learning, to improve risk assessment and validation. The latest emerging therapies will be discussed including bispecific antibodies, oncolytic viral complexes and hormones. Will the super-high level 5 banding for these biologics prove effective or inept? Are current containment planning and solutions truly ensuing the health of workers? These questions will be answered along with unique insights including HPAPI manufacturing technologies.
Attend the conference and join our networking platform with industry professionals to provide you with the expertise to overcome challenges.
DISCUSSION HIGHLIGHTS:
Oncology Antibody-Drug Conjugates (ADC), the ongoing developments and the containment challenges imposed
How to correctly assess, plan and implement the most cost-effective containment
Emerging HPAPI therapies, oncolytic viruses their potential and challenges
Alternative HPAPI manufacturing technologies to reduce powder exposure and improving safety along with enabling continuous manufacturing
The reality of oncology ADC and HPAPI: are most drugs using ‘highly-potent’ to improve brand image? Has 50 years of ADC R&D for oncology with no cure shows signs of no promise?
View the full agenda: www.hpapi-usa.com/PJwl

Lab Asset & Facility Management In Pharma 2019
2019-10-22 - 2019-10-24 | The Westin San Diego, 400 West Broadway, San Diego, CA, 92101, United States
The 2nd annual Lab Asset & Facility Management in Pharma summit is the only industry-led platform to join 120+ senior experts from Lab Operations, Facility Management, Lab Supplies and Procurement across pharma, biotech, CROs and research institutions.

Join your colleagues who are beginning to implement end-to-end asset management programs to optimize spend and gain better visibility of inventory and equipment lifecycles in order to maximize capital efficiency.
At the event, you’ll delve into your core challenges, including:

How to increase R&D productivity and avoid unnecessary downtime
Revise the operating model for lab facility and asset supplies
Optimize utilization of lab equipment and facility footprint
Explore new technologies and IoT for asset monitoring and predictive maintenance
Extend and manage your equipment lifecycle
Evaluate your relationships and collaborations with OEMs

Don’t miss out on this one of a kind meeting to engage with your peers and re-define best practice for tomorrow’s operations!
To learn more and to register online, visit: https://ter.li/lafm-listing-home

2nd Targeted Protein Degradation Summit
2019-10-22 - 2019-10-24 | Hilton Boston Logan Airport, One Hotel Drive, Boston, MA, 02128, United States
Finally Drug the “Undruggable” Through Targeted Protein Degradation. Encapsulating the excitement of the field of protein degradation; The 2nd TPD Summit 2019 is the definitive, comprehensive and industry-dedicated conference for the field of protein degradation – focused on optimizing target validation, improving medicinal chemistry & rational design and ultimately accelerating the translation of selective, bioavailable and effective protein degraders into clinical trials.
With 50+ speakers, 40+ late-breaking case studies, 3 dedicated streams, 6 technical deep-dives & 400+ attendees, TPD 2019 is the most comprehensive and the definitive guide for large pharma, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.
As the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results, it’s clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential.
View the program and speaker list here: https://ter.li/idctdn

SAPHEX 2019
2019-10-23 - 2019-10-24 | GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, South Africa
SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.

SAPHEX serves a primary platform for both local and international companies working in the South African or Africa pharmaceutical manufacturing industry. The exhibition brings together key visiting pharma suppliers and buyers, with a range of exhibitors from across the pharmaceutical sector.
Don’t miss out on your chance to participate at this event.
To learn more about this event and to register online, visit www.saphex.co.za

Lyophilization USA
2019-10-23 - 2019-10-24 | Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, 02199, United States
SMi Presents the 5th annual
Lyophilization USA Conference
Date: October 23-24, 2019
Workshop: October 25, 2019
Location: Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, USA
Website: www.lyophilisation-usa.com/PJBan
About Lyophilization USA
The SMi Group is pleased to invite you to the 5th Annual Lyophilization USA Conference arranged to take place on the 23rd and 24th October 2019, in Boston.

The current list of FDA-approved biopharmaceuticals contains up to 50% of injectables and approximately a third of all parenterals being lyophilized, which suggests it is the optimal way of ensuring stability in products that are unstable in aqueous solution. This instability or degradation can result in suboptimal product performance and even toxicity in worst cases indicating the need for lyophilization despite it’s inherently expensive running costs and time-consuming process.
Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of lyophilization. Benchmark and network with industry leaders and discuss the most up to date and relevant topics that delve into alternative lyophilization approaches, applied statistical modelling, fresh views on scaling up and tech transfer, pre- and post-product characterization. regulation and beyond.
DISCUSSION HIGHLIGHTS:
Gain valuable insight into the most current challenges and considerations when working with highly concentrated and sensitive formulations
Explore new and innovative approaches in model-based studies that utilise the power of statistical analysis to improve process development and understanding
Discuss the future outlook of lyophilization through trends in alternative approaches
Discover updates on the leading PAT technologies such as controlled nucleation, continuous freeze drying, low-frequency Raman, vacuum-foam drying and more.
Listen to key opinion leaders and experts from regulatory bodies speak about expectations and the assessment of reliable technologies in the market
View the full agenda: www.lyophilisation-usa.com/PJBan
Contact Info:
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

3rd Annual NASH Summit Europe 2019
2019-10-23 - 2019-10-25 | The Waldorf Hilton, London, Aldwych, London, WC2B 4DD, United Kingdom
Welcome to Europe’s Gathering of NASH Drug Developers: The 3rd NASH Summit Europe

Deepen Understanding of the Role of Liver Fibrosis in NASH
Confidently Meet Regulatory Guidelines
Define Clinical Trial Endpoints

Returning as the only NASH forum exclusively facilitating industry-to-industry dialogue and collaboration in Europe; the 3rd NASH Summit Europe will once again showcase leading data and leverage expert insights to advance pipeline success in NASH.
“The NASH Summit was unlike any scientific meeting I have ever been to. Everyone who attended was interested in some aspect of drug development for NASH. I truly enjoyed the “applied science” focus of the meeting as it helped me where I most needed the help. The opportunity to network and learn informally in the poster session and during receptions was excellent.”
Eli Lilly
See & hear from the 3rd NASH Summit Boston attendees to better understand how the NASH Summit is uniquely dedicated to advancing the therapeutic potential of NASH therapeutic
To learn more about this event, and to register online, visit https://nash-europe.com/
Contact:
Phone – +44 (0)20 3141 8700
Email – info@hansonwade.com

Neuromuscular Drug Development Summit (NMD)
2019-10-23 - 2019-10-25 | The Westin Boston Waterfront, 425 Summer Street, Boston, Massachusetts, 02210, United States
Now in its 2nd year, the industry-focused NMD Summit will overcome the challenges preventing neuromuscular drug developers bringing truly transformative therapeutics to market.
With an emphasis on ALS, SMA, DMD and other rare diseases, 18 expert speakers from the likes of Biogen, Audentes and PTC Therapeutics will share their insights across 3 packed days.
Join 90+ neuromuscular stakeholders at this definitive forum to exchange novel ideas, gather lessons learned and establish new collaborations.
To learn more about this event, and to register online, visit https://ter.li/bgvvh7

BioNetwork 2019
2019-10-23 - 2019-10-25 | The Ritz-Carlton Laguna Niguel, CA
BioNetwork
October 23 – 25, 2019
The Ritz-Carlton Laguna Niguel, CA
For the past 15 years, BioNetwork has brought together the most senior-level decision makers in pharma and biotech deal-making (CEOs of BioTechs, VPs of BD from Big Pharma). Meet the right people and create the ideal partnerships.

Discount Code: BN19PJ
To learn more about BioNetwork 2019 and to register online, visit http://bit.ly/2ZnZSRN

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress
2019-10-24 - 2019-10-25 | Boston, USA
MarketsandMarkets is proud to announce the 2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress to be held on 24th-25th October 2019 in Boston, USA. With the increasing recognition of real-world data opportunities and challenges within the pharmaceutical and biotech industry, life sciences organizations face clear decisions on how specifically to put resources into real-world evidence capacities.
Real-World Evidence can possibly change the way life sciences associations use advancements to increase further clinical bits of knowledge and enable them and payers to collaborate like never before. After the successful inaugural, the 2nd Annual Real-World Data and Life Science Analytics Congress will hold discussions on accelerating the adoption of Real-world evidence within the industry while understanding the capabilities of newer technologies for evidence generation. The congress will also address upcoming changes in the regulatory landscape with the recent framework by the FDA.
Our aim for the 2nd Annual Real-World Data and Life Science Analytics Congress is to unite all stakeholders to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.

Skin Microbiome & Cosmeceutical Congress: USA
2019-10-29 - 2019-10-30 | Paradise Point Resort & Spa, San Diego, USA, United States
This conference is dedicated to exploring the burgeoning field of skin microbiome research, with case studies focusing on topics such atopic dermatitis, psoriasis, acne, and allergy, and the microbiome-based products being developed to fight these diseases. The conference will also provide insight into the future of microbiome-based cosmetics, with numerous presentations on trial design, commercial strategy, and consumer awareness and expectations.

Inflammasome Therapeutics Summit
2019-10-29 - 2019-10-31 | Revere Hotel Boston Common, 200 Stuart Street, Boston, MA, 02116, United States
The inaugural Inflammasome Therapeutics Summit (ITS) is the industry’s first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share their latest scientific progress and address the current challenges drug developers are facing.

Join 60+ of your peers and be part of this unique opportunity to engage in cross-industry discussions and presentations from over 19 expert speakers.
With a mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases, ITS will hone in on the latest developments, insights and science to elevate clinically effective inflammasome therapeutic pipelines.
Developed in combination with experts from Nodthera, Pfizer and IFM Therapeutics and other leading organisations.
To learn more about this event, and to register online, visit https://ter.li/su3nfj

The Pharma Gorilla
2019-11-07
After a successful and overwhelming response of the Pharma Gorilla conference Mumbai on March 27, The Conference Gorilla is organizing its 2nd and 3rd Edition of The Pharma on following dates and venues.

The Pharma Gorilla | June 26, 2019 | Le Meridien Singapore, Sentosa
The Pharma Gorilla | Nov 07, 2019 | New Delhi, India

The objective of this conference to share expertise addressing the current advancements involved in the Pharmaceutical industry. The knowledgeable intriguing sessions will create an ideal platform to get acquainted with the latest trends, advancements, and future of the pharmaceutical sciences. It is a wonderful opportunity for all the participants as it provides a networking opportunity to collaborate with the world class Pharmaceutical and healthcare industry.
The conference program have been designed in such way which can cover the trending topics under Keynote session, exclusive presentation, product lunch, panel and round table discussion and it also provides a meaningful information.
The Pharma Gorilla provides a perfect platform for conducting presentations, keynote sessions, sharing the knowledge, one on one meeting with your potential audience and getting acquainted with the latest developments in the pharmaceutical and healthcare industry to stand out of the competition.
Target Audience: 150+ Pharma professional from all over the Asia so I think it would be a good platform for you to accomplish your networking with the key decision makers of pharmaceutical companies, software development companies, CRO, manufacturing, formulation, digital marketing and data management companies.
Glimpse of Conference Agenda!
Conference Panels

Artificial Intelligence in Pharma and Healthcare
A disruptive take on marketing: Digital Marketing comes to Pharma
Scope of E-Pharmacy in Asia: Bringing New Dimensions to Pharma Industry
Latest Trends in Formulation Development: A Global Perspective
The Impact of Regulatory Reform on Innovation in Drug Delivery Systems

Roundtable Discussion

Improving patient engagement and experience to improve clinical trials

Keynote Session

Innovation-driven and emerging technologies of Pharma Industry in Asia
The Global Pharma Industry: Policies, Regulations and Key Trends 2019-2020

Exclusive Presentation

Role of IPR in pharmaceutical industry
Career Growth Opportunities in the pharmaceutical industry
Improving Biosimilars in manufacturing data

For any query, contact us at contact@theconferencegorilla.com or IN: +91-813-004-7071 | US: +1-347-480-1588

TIDES Europe: Oligonucleotide & Peptide Therapeutics
2019-11-12 - 2019-11-15 | RAI Amsterdam | Amsterdam, Netherlands
TIDES Europe is Europe’s #1 forum for oligonucleotide and peptide leaders to build successful partnerships and accelerate new products to market.

400+ OLIGONUCLEOTIDE AND PEPTIDE SCIENTISTS AND EXECUTIVES
Fast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Asia and Europe.
40+ CASE STUDIES AND NEW DATA PRESENTATIONS
Hear best practices, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production.
30+ LEADING EXHIBITORS
Connect with leading manufacturing, technologies, and service providers to drive your promising therapeutic towards commercial success.
Register now at www.TIDESEuropeEvent.com with code “PHARMJ10” and SAVE 10%.

Data Analytics for Pharma Development 2019
2019-11-12 - 2019-11-14 | Hilton Munich City, Rosenheimer Str. 15, München, 81667, Germany
Following a hugely successful event in Amsterdam last year, we’re excited to inform you that the 5th Annual Data Analytics for Pharma Development Forum will be taking place in Munich from the 13-14 November 2019. Read all about it here: Download the 2019 Agenda.

The industry needs to move past the challenge of unstructured data sets and integrating data from multiple sources to begin to work collaboratively with other departments and organisations, as well as create a real world evidence framework for our pharmaceutical development through effective data utilisation. This is why we’ve curated an industry leading program with inside expertise from the top.
So – who exactly will be there?
Scientific Director, Janssen
Principle Data Scientist, Novo Nordisk
Principal Scientist Digitalisation Lead in Large Molecule Research, Roche
Senior Director, Head, Global Real World Evidence Strategy and Analytics, Biogen
Health Informatics Director, AstraZeneca
Vice President AI and Machine Learning, BERG Health
Director, Data Science IKU in EMEA, Celgene
Global HEOR Evidence Expert Lead, Sanofi
Head Quantitative Sciences, Bill & Melinda Gates Medical Research Institute
For the first time ever we also bring you the Start-Up Afternoon, where 5+ innovative data-management start ups demonstrate their technology in lightning-round presentations.
We also know that people learn better when they’re being active, so this year we also running Certificate Course in Data Analytics to deep-dive into data strategy, advanced analytics and machine learning & AI to ensure you’re at the forefront of innovation.
We encourage the sharing of challenges and success stories through an interactive program – but most importantly, we facilitate open discussions during networking opportunities where our delegates from Big Pharma, biotech, and start-ups will be looking to you to inform their next step on how to optimise their data strategy.
With 50+ attendees and an expert speaker faculty of over 20 senior decision makers, the Data Analytics forum is Europe’s industry leading event.
Download the 2019 Agenda here to find out more about the forum

Protein Engineering Congress EU
2019-11-12 - 2019-11-13 | Radisson Blu Hotel Frankfurt, Franklinstrasse 65, 60486, Frankfurt am Main, Germany
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimise performance greater than ever.
Introducing the European Protein Engineering Congress, dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries.
With pharmaceutical, flavour & fragrance, consumer goods, animal feed, and agrochemical sectors all approaching the design, build and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.

5th annual European Microbiome Congress
2019-11-13 - 2019-11-14 | Olympia Conference Centre, Hammersmith Rd, Hammersmith, London W14 8UX
The gut microbiota’s importance in human health and disease progression spreads far wider than just gastro-intestinal conditions. The immune, nervous and metabolic systems couple the microbiome with the rest of the body and thus play a crucial and interlinking role in extra-intestinal diseases including neurological, cancer and metabolic conditions.

For the 5th annual European Microbiome Congress, we’ve shifted the focus from gastro-intestinal to extra-intestinal as we examine the latest pre-clinical and clinical data demonstrating the gut microbiota’s role in some of the world’s most critical and costly diseases in modern society.
Join key opinion leaders from across academia and industry to examine the latest research data. This is your opportunity to find out how others plan to translate the latest understanding of the gut-microbiome into therapeutic drugs that have the power to treat cancer, metabolic, neurodegenerative and psychiatric disorders.
To learn more about 5th annual European Microbiome Congress, and to register online, visit https://microbiomecongress.com

Skin Microbiome Congress EU
2019-11-13 - 2019-11-14 | Olympia London, Hammersmith Road, Kensington, London, W14 8UX
With 2.35 billion Euros being spent on cosmetic product R&D in Europe, and Skin Microbiome being “2019’s hottest skin care trend” – a claim supported by major market researchers and beauty bibles, are you ready for the next generation of skin care?
We are bringing you the first data focused Skin Microbiome event with two concurrent tracks focused on the hard data and commercial sides of skin microbiome:

Data Track: focuses on the hard data that supports and legitimises product claims and drives increased understanding of the skin microbiome.
Commercial Track: tackles the challenges faced when building a commercially viable skin microbiome company, optimising your supply chain and executing successful marketing & communication strategies.

Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of:

Effective Networking with 150+ innovators, start-ups, multinational companies and vendors.
Cutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiome.
Consumer Trends – Understand how consumer trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiome.
Clinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeutics.
Competitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed products.
Regulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic product.

With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don’t miss your chance to understand the next generation of natural skincare products!

Ophthalmic Drugs
2019-11-18 - 2019-11-20 | Copthorne Tara Hotel, Scarsdale Place, Kensington, London, W8 5SY, United Kingdom
SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on the 18th-20th November 2019 in London, UK.

The global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market.
With this in mind, this year’s Ophthalmic Drugs conference will explore new discoveries in the treatment of ocular rare disease; innovations in gene therapy; the challenges in drug delivery through a complex barrier; patient comfort and regulatory compliance which make up core components within the Ophthalmic Drug sphere.
NEW FOR 2019:
The brand-new Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ will bring academic perspectives on the future for ocular drug delivery and notified bodies will provide a regulatory insight into this emerging field of ophthalmic drug development.
How will you benefit?
With over 15 expert presentations, the three-day agenda offers you peer-to-peer networking with Global Product Managers, Heads of Drug Development, Senior Directors of Ophthalmology, Heads of Research and Development and many more!
Network and learn from leading professionals such as:
CHAIRS FOR 2019:

Mitchell de Long, Vice President, Chemistry, Aerie Pharmaceuticals
Naj Sharif, Vice President, Global Ophthalmology, Santen Inc, USA

FEATURED SPEAKERS INCLUDE:

Parisa Zamiri, Global Head of Clinical Development in Ophthalmology, Novartis Pharmaceutical Inc.
Gavin Spencer, Executive Vice President and Chief Business Officer, Nicox
Aniz Girach, Chief Medical Officer, ProQR Therapeutics
Daniel Chung, Global Medical Strategy Lead- Ophthalmology, Spark Therapeutics
Michael Ehrlich, Senior Clinical Program Lead – Retinopathies, Boehringer Ingelheim
Peter Morgan-Warren, Medical Assessor, MHRA
William Dallman, Clinical Development Manager, Eyenuk

For more information and to register, visit: www.ophthalmicdrugs.com/pj
Early-Bird Rates

BOOK BY 28TH JUNE AND SAVE £300
BOOK BY 30TH SEPTEMBER AND SAVE £100

Social Media Handles
Follow us on LinkedIn ‘SMi Pharma’, Twitter @SMiPharm and use #OphthalmicDrugs
Contact Info:
T: +44 (0) 20 7827 6164
E: nhoward@smi-online.co.uk

3rd Annual Anti-Fibrotic Drug Development Summit (AFDD) 2019
2019-11-18 - 2019-11-20 | Revere Hotel Boston Common, 200 Stuart Street, Boston, MA, 02116, United States
AFDD is back for its third year as the only conference to bring together industry leaders, clinicians and academic experts focused on finding an effective anti-fibrotic treatment.

Over 3 days packed with compelling case studies, diverse panels and varied networking opportunities, you’ll glean insights from industry and academic leaders across fibrotic disease areas. The 2019 agenda will reflect the strides taken by the community over the past year as well as forming the future of anti-fibrotic drug development.
To learn more about this event, and to register online, visit https://afdd-summit.com/
Contact:
Phone – (+1) 617 455 4188
Email – info@hansonwade.com

1st RNA Editing Summit 2019
2019-11-19 - 2019-11-20 | Revere Hotel Boston Common, 200 Stuart St, Boston, MA, 02116, United States
Translating Emerging RNA Editing Approaches for Therapeutic Applications.
As CRISPR genome editing struggles to overcome key specificity and delivery challenges in its pursuit to realize therapeutic applications, the 1st RNA Editing Summit 2019 accelerates the translation and commercialization of RNA editing for an array of research and therapeutic applications.
As the therapeutic potential of RNA editing explodes, discover the fundamental mechanisms of RNA editing, such as recruiting endogenous ADARs with encodable guideRNAs, and learn about the novel approaches being developed to precisely and efficiently deliver intended RNA edits. With the temporary nature of RNA editing providing a huge opportunity in many areas beyond genetic diseases, uncover how to recruit endogenous editing enzymes and ultimately deliver safe and effective transcriptome edits.
Join RNA, functional genomic, cell biology and immuno-oncology experts from large pharma, biotech and academia at the 1st RNA Editing Summit 2019 in the pursuit of translating emerging RNA editing mechanisms into therapeutic reality.
To learn more about this event, and to register online, visit https://ter.li/jikni6

3rd Annual Dermatology Drug Development Summit
2019-11-19 - 2019-11-21 | Aloft Boston Seaport District, Boston, MA
The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs, in the treatment of high unmet need.
The 3rd Annual Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways, to unveiling critical preclinical insights, discussing formulation strategies, defining the optimal clinical development plans or evaluating commercialization approaches.
Join peers and leaders in this space for an exclusive three-day meeting of comprehensive discussion, sharing of latest advances and pioneering insights, and networking opportunities.
Hear from 30+ experts including:

Sonya Abraham, Head of New Treatment Strategies, Immunology, UCB
David Rubenstein, CSO, Dermavant Sciences
Kendall Marcus, Director – Division of Dermatology & Dental Products, FDA
Michael Kuligowski, Executive Medical Director – Inflammation & Autoimmunity, Incyte Corporation
John Harris, Vice Chair of Dermatology & Director, Vitiligo Clinic & research Center, University of Massachusetts Medical School
Suma Krishnan, Founder & COO, Krystal Biotech

Across an end-to-end, comprehensive agenda, learn from case studies on:

How to enhance preclinical activities
The latest advances in translational research
How to advance topical drug development and formulation approaches
How to accelerate clinical development and what are the latest clinical results
How to tackle the evolving regulatory and commercial landscape in dermatology

Find out more here: https://ter.li/jj7wxg

Gene Therapy Analytical Development
2019-11-19 - 2019-11-21 | Renaissance Boston Waterfront Hotel 606 Congress Street Boston, Boston, MA, 02210, United States
The inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency, quality and safety of gene therapy products.

Focused specifically on addressing the unique analytical challenges posed by gene therapy vectors, this technical scientific meeting will unite the ‘boots on the ground’ scientists grappling with these challenges first-hand.
Delving into technical analytics to assess potency, capsid integrity, empty vs full capsids and viral titers of AAV and lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development.
To learn more and to register online, visit https://ter.li/z1fc6v
